Clinical Trials Logo

Clinical Trial Summary

The investigators hypothesize that opioid prescription guided by patient pharmacogenetic profile will diminish opioid-associated undesirable effects by 50% and improve medication compliance.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03498014
Study type Interventional
Source Centre Hospitalier Universitaire de Nimes
Contact
Status Withdrawn
Phase N/A
Start date July 2022
Completion date December 2023